The life sciences industry has been severely impacted by the COVID-19 pandemic, with hundreds of clinical trials halted and most ongoing trials disrupted in one way or the other. In the wake of this disruption, enterprises are increasingly investing in digital technologies to adapt to the evolving drug development model (such as increasing adoption of virtual or/and hybrid trials) and looking at various approaches to reduce costs, minimize operational disruptions, and enhance overall efficiencies.

Service providers are helping enterprises embrace the paradigm shift by delivering services and solutions across the life sciences operations value chain. From offering cost-effective pharmacovigilance services and technology-driven commercial operations, to supporting enterprises on domain-intensive clinical trial operations, service providers are partnering with biopharmas and medical device manufacturers to manage their evolving priorities and growing business needs.

In this research, we present detailed profiles and assessments of 31 service providers featured on the Life Sciences Operations Services PEAK Matrix®.

Scope

Function: life sciences Business Process Services (BPS)

Industry: life sciences BPS

Geography: global

Contents

This report provides detailed profiles and assessments of 31 operations service providers featured on Everest Group’s Life Sciences Operations Services PEAK Matrix®. Each service provider profile provides a comprehensive picture of its service focus, key IP/solutions, domain investments, strengths, and limitations.

Membership(s)

Life Sciences Business Process

Sourcing and Vendor Management